These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 5150882)

  • 1. [Treatment of Duhring-Brocq disease with chloraminophene].
    Degos R; Civatte J; Larrègue M
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):425-31. PubMed ID: 5150882
    [No Abstract]   [Full Text] [Related]  

  • 2. [Duhring-Brocq disease and anti-basal membrane autoantibodies. Clinical, serlogic, histo-immunologic and ultrastructural data].
    Thivolet J; Beyvin AJ
    Arch Belg Dermatol Syphiligr; 1969; 25(2):241-55. PubMed ID: 5401544
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunology of the pemphigoid form of Duhring-Brocq disease].
    Thivolet J; Beyvin AJ
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):369-90. PubMed ID: 4948643
    [No Abstract]   [Full Text] [Related]  

  • 4. [Histological and clinicoimmunological studies in 40 cases of Duhring-Brocq disease].
    Moulin G; Beyvin A; Valignat P
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):410-2. PubMed ID: 5150879
    [No Abstract]   [Full Text] [Related]  

  • 5. [Personal experience with methotrexate in the treatment of various bullous diseases (Duhring-Brocq, pemphigus)].
    Basset A; Bergoend H; Grosshans E; Heid E; Maleville J
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):371-6. PubMed ID: 5510728
    [No Abstract]   [Full Text] [Related]  

  • 6. [Duhring-Brocq disease and anti-basal membrane antibodies].
    Thivolet J; Beyvin AJ; Leung TK; André
    Bull Soc Fr Dermatol Syphiligr; 1968; 75(5):639-43. PubMed ID: 4883262
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value of immunofluorescence in severe bullous dermatitis].
    Bureau B
    Sem Hop; 1972 Apr; 48(17):1209-21. PubMed ID: 4341283
    [No Abstract]   [Full Text] [Related]  

  • 8. [Immunosuppressive agents and bullous diseases].
    Beurey J; Weber M; Vadot J; Touret D
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(3):384-9. PubMed ID: 5510732
    [No Abstract]   [Full Text] [Related]  

  • 9. [Auuto-immunity in Duhring-Brocq disease].
    Thivolet J; Beyvin AJ; Perrot H; André
    Bull Soc Fr Dermatol Syphiligr; 1969; 76(3):463-7. PubMed ID: 4931284
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical, histological, biological and therapeutic comparisons in 149 cases of Duhring-Brocq disease].
    Degos R; Civatte J; Belaïch S; Bonvalet D
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):391-6. PubMed ID: 5150874
    [No Abstract]   [Full Text] [Related]  

  • 11. [Treatment of Duhring-Brocq's disease with chloraminophen. Preliminary note].
    Larrègue M; Civatte J; Dao C; Degos R
    Bull Soc Fr Dermatol Syphiligr; 1970; 77(6):794-7. PubMed ID: 5512022
    [No Abstract]   [Full Text] [Related]  

  • 12. [Duhring-Brocq disease, signal symptom of a chronic lymphoid leukemia].
    François A; Carli-Basset C; Ginies G; Leroy J; Bruneau P
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(1):60-2. PubMed ID: 5565935
    [No Abstract]   [Full Text] [Related]  

  • 13. ["Pemphigoid" form of the Dhuring-Brocq disease. Clinical form or autonomous disease?].
    Bureau Y; Barrière H; Litoux P; Bureau B; Welin J
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):319-28. PubMed ID: 4948641
    [No Abstract]   [Full Text] [Related]  

  • 14. [Duhring-Brocq disease with antibodies and methotrexate. Current clinical and biological results].
    Beurey J; Weber M; Fournier A; Siboul M; Guibert M
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):431-2. PubMed ID: 5004841
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies in bullous diseases. Immunofluorescent serologic tests.
    Peck SM; Osserman KE; Weiner LB; Lefkovits A; Osserman RS
    N Engl J Med; 1968 Oct; 279(18):951-8. PubMed ID: 4300571
    [No Abstract]   [Full Text] [Related]  

  • 16. [Specificity of autoantibodies discovered in pemphigus and in the bullous variety of Duhring-Brocq disease].
    Thivolet J; Beyvin AJ; André D
    Ann Dermatol Syphiligr (Paris); 1970; 97(5):534-41. PubMed ID: 4250902
    [No Abstract]   [Full Text] [Related]  

  • 17. [Curative treatment of Dühring-Brocq disease using BCG vaccination (part 2)].
    Bolgert M
    Sem Hop; 1973 Dec; 49(52):3497-507. PubMed ID: 4365824
    [No Abstract]   [Full Text] [Related]  

  • 18. [Development and prognosis of Duhring-Brocq disease in aged patients. Apropos of 16 cases].
    Heid E; Bergoend H; Roveri D; Grosshans E; Maleville J; Basset A
    Bull Soc Fr Dermatol Syphiligr; 1971; 78(4):404-9. PubMed ID: 5150877
    [No Abstract]   [Full Text] [Related]  

  • 19. [Duhring and Brocq dermatitis herpetiformis. Recent immunologic findings. Personal observations in a patient].
    Cicala O; Marasco A; Conte M
    Clin Ter; 1989 Jun; 129(6):437-44. PubMed ID: 2526705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Autoimmunity in bullous dermatoses].
    Thivolet J; Beyvin AJ; André D
    Presse Med (1893); 1969 Dec; 77(53):1973-4. PubMed ID: 4983977
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.